NPAS2 and non-Hodgkin lymphoma: Differential NPAS2 expression has been associated with patient outcomes in tumors, lung tumors, non-Hodgkin's lymphoma, and other diseases [34], and nucleotide variants in the NPAS2 gene were related to cancer patients' outcomes.